Cola cure? Study sheds light on soda’s potential for common holiday medical emergency

Researchers performed a randomized controlled trial (RCT) to evaluate the safety and effectiveness of cola in relieving esophageal meal bolus impaction.

FDA hits Natco with warning letter over India facility, suspends product shipments to US

Manufacturer Natco Pharma was hit with a warning letter earlier this month over violations at its facility in the Indian state of Telangana, following an

April 17, 2024

The impact of implementing a high sensitivity assay for cardiac troponin I on long term outcomes in patients with suspected acute coronary syndrome

Researchers from the United Kingdom evaluated the use of a high-sensitivity assay to measure cardiac troponin I and its impact on myocardial infarction (MI) risk

November 30, 2023

Mainz Biomed Presents Groundbreaking Results of ColoFuture Study – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Study results 18.10.2023 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz

October 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.